6.
. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol Psychiatry. 2017; 23(5):1181-1188.
PMC: 6660151.
DOI: 10.1038/mp.2017.154.
View
7.
Wendland J, Moya P, Timpano K, Anavitarte A, Kruse M, Wheaton M
. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry. 2009; 66(4):408-16.
PMC: 2775716.
DOI: 10.1001/archgenpsychiatry.2009.6.
View
8.
Altemus M, Jacobson K, Debellis M, Kling M, Pigott T, Murphy D
. Normal CSF oxytocin and NPY levels in OCD. Biol Psychiatry. 1999; 45(7):931-3.
DOI: 10.1016/s0006-3223(98)00263-7.
View
9.
Scahill L, Riddle M, Ort S, King R, Goodman W, Cicchetti D
. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997; 36(6):844-52.
DOI: 10.1097/00004583-199706000-00023.
View
10.
Canals J, Hernandez-Martinez C, Cosi S, Voltas N
. The epidemiology of obsessive--compulsive disorder in Spanish school children. J Anxiety Disord. 2012; 26(7):746-52.
DOI: 10.1016/j.janxdis.2012.06.003.
View
11.
Herold C, Becker T
. Genetic association analysis with FAMHAP: a major program update. Bioinformatics. 2008; 25(1):134-6.
DOI: 10.1093/bioinformatics/btn581.
View
12.
Heilig M
. The NPY system in stress, anxiety and depression. Neuropeptides. 2004; 38(4):213-24.
DOI: 10.1016/j.npep.2004.05.002.
View
13.
Caberlotto L, Fuxe K, Overstreet D, Gerrard P, Hurd Y
. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res Mol Brain Res. 1998; 59(1):58-65.
DOI: 10.1016/s0169-328x(98)00137-5.
View
14.
Arnold P, Sicard T, Burroughs E, Richter M, Kennedy J
. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006; 63(7):769-76.
DOI: 10.1001/archpsyc.63.7.769.
View
15.
Walitza S, Marinova Z, Grunblatt E, Lazic S, Remschmidt H, Vloet T
. Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive-compulsive disorder. Neurosci Lett. 2014; 580:100-3.
PMC: 4167890.
DOI: 10.1016/j.neulet.2014.07.038.
View
16.
Neumann C, Taub M, Younkin S, Beaty T, Ruczinski I, Schwender H
. Analytic power and sample size calculation for the genotypic transmission/disequilibrium test in case-parent trio studies. Biom J. 2014; 56(6):1076-92.
PMC: 4206700.
DOI: 10.1002/bimj.201300148.
View
17.
Fireman B, Koran L, Leventhal J, Jacobson A
. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry. 2001; 158(11):1904-10.
DOI: 10.1176/appi.ajp.158.11.1904.
View
18.
Spielman R, McGinnis R, Ewens W
. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993; 52(3):506-16.
PMC: 1682161.
View
19.
Movafagh S, Hobson J, Spiegel S, Kleinman H, Zukowska Z
. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 2006; 20(11):1924-6.
DOI: 10.1096/fj.05-4770fje.
View
20.
Walitza S, Scherag A, Renner T, Hinney A, Remschmidt H, Herpertz-Dahlmann B
. Transmission disequilibrium studies in early onset of obsessive-compulsive disorder for polymorphisms in genes of the dopaminergic system. J Neural Transm (Vienna). 2008; 115(7):1071-8.
DOI: 10.1007/s00702-008-0051-6.
View